All resources
Research

Validation of nocturnal resting heart rate and heart rate variability in consumer wearables

Validation of nocturnal resting heart rate and heart rate variability in consumer wearables

Description

This peer-reviewed validation study evaluated the accuracy of tracking nocturnal resting heart rate (RHR) and heart rate variability (HRV) across five popular consumer wearable devices against a gold-standard electrocardiogram (ECG) reference.

Conducting longitudinal monitoring over 536 cumulative nights of sleep, researchers tracked metrics to establish rigorous performance benchmarks. The findings demonstrate that interdevice accuracy varies significantly, with Oura Ring Gen3 and Oura Ring 4 achieving the highest statistical concordance and lowest absolute percentage error for both RHR and HRV metrics. 

Expert perspective

“As RHR and HRV are important physiological vital signs that provide insight into general health, recovery, and sleep performance, it is vital to assess the validity and reliability of the wearable sensors reporting these data.”


Notes

*Currently not available through the John Hancock Vitality Program in Guam, Puerto Rico, New Mexico, North Dakota, New York, and Vermont.

Vitality is the provider of the John Hancock Vitality Program in connection with policies issued by John Hancock. John Hancock Vitality Program rewards and discounts are available only to the person insured under the eligible life insurance policy, may vary based on the type of insurance policy purchased and the state where the policy was issued, are subject to change and are not guaranteed to remain the same for the life of the policy. John Hancock insurance products are issued by: John Hancock Life Insurance Company (U.S.A.), Boston, MA 02116 (not licensed in New York) and John Hancock Life Insurance Company of New York, Valhalla, NY 10595. MLINY051023599-1


Could your organization benefit from Oura?

Let’s discuss your needs and discover how Oura can help you.

Contact us